Citadel Advisors »

Estrella Immunopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Estrella Immunopharma (ESLA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Estrella Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Estrella Immunopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Estrella Immunopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $60k 50k 1.19
2025-06-30 $43k 50k 0.86
2025-03-31 $85k 92k 0.93
2024-09-30 $17k 15k 1.16

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Estrella Immunopharma

Vanguard Group
Geode Capital Management
UBS Group
Citadel Advisors
Atw Spac Management
BlackRock
State Street Corporation
Renaissance Technologies
XTX Topco
Maso Capital Partners
Tower Research Capital
SBI Securities

View all funds holding Estrella Immunopharma